RESUMEN
Pulmonary veno-occlusive disease (PVOD) and pulmonary capillary hemangiomatosis are rare types of histopathological substrates within the spectrum of pulmonary arterial hypertension (PAH) with a very poor prognosis. They are characterized by a widespread fibroproliferative process of the small caliber veins and/or capillaries with sparing of the larger veins, resulting in a pre-capillary pulmonary hypertension phenotype. Clinical presentation is unspecific and similar to other PAH etiologies. Definitive diagnosis is obtained through histological analysis, although lung biopsy is not advised due to a higher risk of complications. However, some additional findings may allow a presumptive clinical diagnosis of PVOD, particularly a history of smoking, chemotherapy drug use, exposure to organic solvents (particularly trichloroethylene), low diffusing capacity for carbon monoxide (DLCO), exercise induced desaturation, and evidence of venous congestion without left heart disease on imaging, manifested by a classical triad of ground glass opacities, septal lines, and lymphadenopathies. Lung transplant is the only effective treatment, and patients should be referred at the time of diagnosis due to the rapid progression of the disease and associated poor prognosis. We present a case of a 58-year-old man with PAH with features of venous/capillary involvement in which clinical suspicion, prompt diagnosis, and early referral for lung transplantation were determinant factors for the successful outcome.
A doença veno-oclusiva pulmonar (DVOP) e a hemangiomatose capilar pulmonar são tipos raros de substratos histopatológicos dentro do espectro da hipertensão arterial pulmonar (HAP) com prognóstico muito ruim. Caracterizam-se por um processo fibroproliferativo generalizado das veias e/ou capilares de pequeno calibre com preservação das veias maiores, resultando em um fenótipo de hipertensão pulmonar pré-capilar. A apresentação clínica é inespecífica e semelhante a outras etiologias de HAP. O diagnóstico definitivo é obtido por meio de análise histológica, embora a biópsia pulmonar não seja aconselhada devido ao maior risco de complicações. No entanto, alguns achados adicionais podem permitir um diagnóstico clínico presuntivo de DVOP, especialmente história de tabagismo, uso de drogas quimioterápicas, exposição a solventes orgânicos (particularmente tricloroetileno), baixa capacidade de difusão do monóxido de carbono (DLCO), dessaturação ao esforço e evidências de doença venosa sem doença cardíaca esquerda no exame de imagem, manifestada por uma tríade clássica de opacidades em vidro fosco, linhas septais, e linfadenopatias. O transplante pulmonar é o único tratamento eficaz e os pacientes devem ser encaminhados no momento do diagnóstico, devido à rápida progressão da doença e ao prognóstico ruim. Apresentamos o caso de um homem de 58 anos com HAP com características de envolvimento venoso/capilar em que a suspeita clínica, o pronto diagnóstico e o encaminhamento precoce para transplante pulmonar foram determinantes para um bom desfecho.
Asunto(s)
Enfermedad Veno-Oclusiva Pulmonar , Humanos , Masculino , Persona de Mediana Edad , Enfermedad Veno-Oclusiva Pulmonar/diagnóstico por imagen , Hipertensión Arterial Pulmonar/etiología , Hipertensión Pulmonar/etiologíaRESUMEN
Resumo A doença veno-oclusiva pulmonar (DVOP) e a hemangiomatose capilar pulmonar são tipos raros de substratos histopatológicos dentro do espectro da hipertensão arterial pulmonar (HAP) com prognóstico muito ruim. Caracterizam-se por um processo fibroproliferativo generalizado das veias e/ou capilares de pequeno calibre com preservação das veias maiores, resultando em um fenótipo de hipertensão pulmonar pré-capilar. A apresentação clínica é inespecífica e semelhante a outras etiologias de HAP. O diagnóstico definitivo é obtido por meio de análise histológica, embora a biópsia pulmonar não seja aconselhada devido ao maior risco de complicações. No entanto, alguns achados adicionais podem permitir um diagnóstico clínico presuntivo de DVOP, especialmente história de tabagismo, uso de drogas quimioterápicas, exposição a solventes orgânicos (particularmente tricloroetileno), baixa capacidade de difusão do monóxido de carbono (DLCO), dessaturação ao esforço e evidências de doença venosa sem doença cardíaca esquerda no exame de imagem, manifestada por uma tríade clássica de opacidades em vidro fosco, linhas septais, e linfadenopatias. O transplante pulmonar é o único tratamento eficaz e os pacientes devem ser encaminhados no momento do diagnóstico, devido à rápida progressão da doença e ao prognóstico ruim. Apresentamos o caso de um homem de 58 anos com HAP com características de envolvimento venoso/capilar em que a suspeita clínica, o pronto diagnóstico e o encaminhamento precoce para transplante pulmonar foram determinantes para um bom desfecho.
Abstract Pulmonary veno-occlusive disease (PVOD) and pulmonary capillary hemangiomatosis are rare types of histopathological substrates within the spectrum of pulmonary arterial hypertension (PAH) with a very poor prognosis. They are characterized by a widespread fibroproliferative process of the small caliber veins and/or capillaries with sparing of the larger veins, resulting in a pre-capillary pulmonary hypertension phenotype. Clinical presentation is unspecific and similar to other PAH etiologies. Definitive diagnosis is obtained through histological analysis, although lung biopsy is not advised due to a higher risk of complications. However, some additional findings may allow a presumptive clinical diagnosis of PVOD, particularly a history of smoking, chemotherapy drug use, exposure to organic solvents (particularly trichloroethylene), low diffusing capacity for carbon monoxide (DLCO), exercise induced desaturation, and evidence of venous congestion without left heart disease on imaging, manifested by a classical triad of ground glass opacities, septal lines, and lymphadenopathies. Lung transplant is the only effective treatment, and patients should be referred at the time of diagnosis due to the rapid progression of the disease and associated poor prognosis. We present a case of a 58-year-old man with PAH with features of venous/capillary involvement in which clinical suspicion, prompt diagnosis, and early referral for lung transplantation were determinant factors for the successful outcome.
RESUMEN
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive and fatal condition that requires early diagnosis, management, and specific treatment. The availability of new disease-modifying therapies has made successful treatment a reality. Transthyretin amyloid cardiomyopathy can be either age-related (wild-type form) or caused by mutations in the TTR gene (genetic, hereditary forms). It is a systemic disease, and while the genetic forms may exhibit a variety of symptoms, a predominant cardiac phenotype is often present. This document aims to provide an overview of ATTR-CM amyloidosis focusing on cardiac involvement, which is the most critical factor for prognosis. It will discuss the available tools for early diagnosis and patient management, given that specific treatments are more effective in the early stages of the disease, and will highlight the importance of a multidisciplinary approach and of specialized amyloidosis centres. To accomplish these goals, the World Heart Federation assembled a panel of 18 expert clinicians specialized in TTR amyloidosis from 13 countries, along with a representative from the Amyloidosis Alliance, a patient advocacy group. This document is based on a review of published literature, expert opinions, registries data, patients' perspectives, treatment options, and ongoing developments, as well as the progress made possible via the existence of centres of excellence. From the patients' perspective, increasing disease awareness is crucial to achieving an early and accurate diagnosis. Patients also seek to receive care at specialized amyloidosis centres and be fully informed about their treatment and prognosis.
Asunto(s)
Humanos , Prealbúmina , Amiloide , Cardiomiopatías , ConsensoRESUMEN
After fourteen decades of medical and technological evolution, infective endocarditis continues to challenge physicians in its daily diagnosis and management. Its increasing incidence, demographic shifts (affecting older patients), microbiology with higher rates of Staphylococcus infection, still frequent serious complications and substantial mortality make endocarditis a very complex disease. Despite this, innovations in the diagnosis, involving microbiology and imaging, and improvements in intensive care and cardiac surgical techniques, materials and timing can impact the prognosis of this disease. Ongoing challenges persist, including rethinking prophylaxis, improving the diagnosis criteria comprising blood culture-negative endocarditis and prosthetic valve endocarditis, timing of surgical intervention, and whether to perform surgery in the presence of ischemic stroke or in intravenous drug users. A combined strategy on infective endocarditis is crucial, involving advanced clinical decisions and protocols, a multidisciplinary approach, national healthcare organization and health policies to achieve better results for our patients.
Após catorze décadas de evolução médica e tecnológica, a endocardite infeciosa continua a desafiar médicos no seu diagnóstico e manejo diário. O aumento da incidência, alterações demográficas (afetando pacientes mais idosos), microbiologia com taxas de infeção por Staphylococcus mais elevadas, com complicações graves ainda frequentes e uma mortalidade substancial tornam a endocardite uma doença muito complexa. Apesar de tudo, a inovação no seu diagnóstico, nomeadamente na área da microbiologia e imagem, e a melhoria nos cuidados intensivos e na cirurgia cardíaca (quanto às técnicas, materiais usados e momento de intervenção) podem ter um impacto no seu prognóstico. Os desafios persistem, incluindo repensar a profilaxia, melhorar os critérios de diagnóstico incluindo a endocardite com culturas negativas e endocardite de prótese valvar, o timing para a intervenção cirúrgica, e sua realização ou não na presença de acidente vascular cerebral isquêmico e em usuários de drogas intravenosas. Uma estratégia combinada na endocardite infeciosa é fundamental, incluindo decisões e protocolos clínicos avançados, um manejo multidisciplinar, organização e políticas de saúde que culminem em melhores resultados para os nossos pacientes.
Asunto(s)
Procedimientos Quirúrgicos Cardíacos , Endocarditis Bacteriana , Endocarditis , Prótesis Valvulares Cardíacas , Infecciones Estafilocócicas , Endocarditis/complicaciones , Endocarditis/diagnóstico , Endocarditis/terapia , Endocarditis Bacteriana/complicaciones , Endocarditis Bacteriana/diagnóstico , Endocarditis Bacteriana/terapia , Prótesis Valvulares Cardíacas/efectos adversos , HumanosRESUMEN
Resumo Após catorze décadas de evolução médica e tecnológica, a endocardite infeciosa continua a desafiar médicos no seu diagnóstico e manejo diário. O aumento da incidência, alterações demográficas (afetando pacientes mais idosos), microbiologia com taxas de infeção por Staphylococcus mais elevadas, com complicações graves ainda frequentes e uma mortalidade substancial tornam a endocardite uma doença muito complexa. Apesar de tudo, a inovação no seu diagnóstico, nomeadamente na área da microbiologia e imagem, e a melhoria nos cuidados intensivos e na cirurgia cardíaca (quanto às técnicas, materiais usados e momento de intervenção) podem ter um impacto no seu prognóstico. Os desafios persistem, incluindo repensar a profilaxia, melhorar os critérios de diagnóstico incluindo a endocardite com culturas negativas e endocardite de prótese valvar, o timing para a intervenção cirúrgica, e sua realização ou não na presença de acidente vascular cerebral isquêmico e em usuários de drogas intravenosas. Uma estratégia combinada na endocardite infeciosa é fundamental, incluindo decisões e protocolos clínicos avançados, um manejo multidisciplinar, organização e políticas de saúde que culminem em melhores resultados para os nossos pacientes.
Abstract After fourteen decades of medical and technological evolution, infective endocarditis continues to challenge physicians in its daily diagnosis and management. Its increasing incidence, demographic shifts (affecting older patients), microbiology with higher rates of Staphylococcus infection, still frequent serious complications and substantial mortality make endocarditis a very complex disease. Despite this, innovations in the diagnosis, involving microbiology and imaging, and improvements in intensive care and cardiac surgical techniques, materials and timing can impact the prognosis of this disease. Ongoing challenges persist, including rethinking prophylaxis, improving the diagnosis criteria comprising blood culture-negative endocarditis and prosthetic valve endocarditis, timing of surgical intervention, and whether to perform surgery in the presence of ischemic stroke or in intravenous drug users. A combined strategy on infective endocarditis is crucial, involving advanced clinical decisions and protocols, a multidisciplinary approach, national healthcare organization and health policies to achieve better results for our patients.
RESUMEN
BACKGROUND: Early identification of patients with infective endocarditis (IE) at higher risk for in-hospital mortality is essential to guide management and improve prognosis. METHODS: A retrospective analysis was conducted of a cohort of patients followed up from 1978 to 2015, classified according to the modified Duke criteria. Clinical parameters, echocardiographic data, and blood cultures were assessed. Techniques of machine learning, such as the classification tree, were used to explain the association between clinical characteristics and in-hospital mortality. Additionally, the log-linear model and graphical random forests (GRaFo) representation were used to assess the degree of dependence among in-hospital outcomes of IE. RESULTS: This study analyzed 653 patients: 449 (69.0%) with definite IE; 204 (31.0%) with possible IE; mean age, 41.3 ± 19.2 years; 420 (64%) men. Mode of IE acquisition: community-acquired (67.6%), nosocomial (17.0%), undetermined (15.4%). Complications occurred in 547 patients (83.7%), the most frequent being heart failure (47.0%), neurologic complications (30.7%), and dialysis-dependent renal failure (6.5%). In-hospital mortality was 36.0%. The classification tree analysis identified subgroups with higher in-hospital mortality: patients with community-acquired IE and peripheral stigmata on admission; and patients with nosocomial IE. The log-linear model showed that surgical treatment was related to higher in-hospital mortality in patients with neurologic complications. CONCLUSIONS: The use of a machine-learning model allowed identification of subgroups of patients at higher risk for in-hospital mortality. Peripheral stigmata, nosocomial IE, absence of vegetation, and surgery in the presence of neurologic complications are predictors of fatal outcomes in machine learning-based analysis.
CONTEXTE: Le dépistage précoce des patients atteints d'endocardite infectieuse (EI) présentant un risque élevé de mortalité à l'hôpital est essentiel pour orienter la prise en charge et améliorer le pronostic. MÉTHODOLOGIE: Une analyse rétrospective a été réalisée sur une cohorte de patients suivis de 1978 à 2015 et classés selon les critères de Duke modifiés. Les paramètres cliniques, les données des échocardiographies et les hémocultures ont été évalués. Des techniques d'apprentissage automatique, comme l'arbre de classification, ont été utilisées pour expliquer l'association entre les caractéristiques cliniques et la mortalité hospitalière. De plus, le modèle log-linéaire et la représentation graphique en forêts aléatoires ont été utilisés pour évaluer le degré de dépendance entre les résultats hospitaliers et l'EI. RÉSULTATS: Cette étude a permis d'analyser 653 patients : 449 (69,0 %) avec une EI avérée; 204 (31,0 %) avec une EI possible; âge moyen de 41,3 ± 19,2 ans; 420 (64 %) étaient des hommes. Mode d'acquisition de l'EI : communautaire (67,6 %), nosocomial (17,0 %), indéterminé (15,4 %). Des complications sont survenues chez 547 patients (83,7 %), les plus fréquentes étant l'insuffisance cardiaque (47,0 %), les complications neurologiques (30,7 %) et l'insuffisance rénale dépendante de la dialyse (6,5 %). La mortalité hospitalière était de 36,0 %. L'analyse de l'arbre de classification a permis d'identifier des sous-groupes présentant une mortalité hospitalière plus élevée : les patients présentant une EI communautaire et des stigmates périphériques à l'admission; et les patients présentant une EI nosocomiale. Le modèle log-linéaire a montré que le traitement chirurgical était lié à une mortalité hospitalière plus élevée chez les patients présentant des complications neurologiques. CONCLUSIONS: L'utilisation d'un modèle d'apprentissage automatique a permis d'identifier des sous-groupes de patients présentant un risque plus élevé de mortalité à l'hôpital. Les stigmates périphériques, l'EI nosocomiale, l'absence de végétation et la chirurgie en présence de complications neurologiques sont des prédicteurs d'issue fatale dans l'analyse basée sur l'apprentissage automatique.
RESUMEN
Background: Cardiovascular mortality is decreasing but remains the leading cause of death world-wide. Respiratory infections such as influenza significantly contribute to morbidity and mortality in patients with cardiovascular disease. Despite of proven benefits, influenza vaccination is not fully implemented, especially in Latin America. Objective: The aim was to develop a regional consensus with recommendations regarding influenza vaccination and cardiovascular disease. Methods: A multidisciplinary team composed by experts in the management and prevention of cardiovascular disease from the Americas, convened by the Inter-American Society of Cardiology (IASC) and the World Heart Federation (WHF), participated in the process and the formulation of statements. The modified RAND/UCLA methodology was used. This document was supported by a grant from the WHF. Results: An extensive literature search was divided into seven questions, and a total of 23 conclusions and 29 recommendations were achieved. There was no disagreement among experts in the conclusions or recommendations. Conclusions: There is a strong correlation between influenza and cardiovascular events. Influenza vaccination is not only safe and a proven strategy to reduce cardiovascular events, but it is also cost saving. We found several barriers for its global implementation and potential strategies to overcome them.
Asunto(s)
Cardiología , Enfermedades Cardiovasculares , Gripe Humana , Enfermedades Cardiovasculares/epidemiología , Enfermedades Cardiovasculares/prevención & control , Consenso , Humanos , Gripe Humana/epidemiología , Gripe Humana/prevención & control , América Latina/epidemiología , Estados Unidos , VacunaciónRESUMEN
Abstract Background: The impact of gender on the outcome of patients hospitalized with infective endocarditis (IE) is not fully understood. Objective: To verify the association between gender and the clinical profile of patients hospitalized with IE, treatment strategies, and clinical outcomes. Methods: This is a retrospective nationwide study of patients hospitalized with IE, based on hospital admissions between 2010 and 2018 in Portugal. Descriptive statistics were used to present variables. An inferential analysis was performed using multiple logistic regression. A 95% confidence interval and a 5% significance level were considered. Results: In total, 3266 (43.1%) women and 4308 (56.9%) men were hospitalized with IE. The women were older (76 vs 69 years old, p<0.001), more frequently presented arterial hypertension (39.8% vs 35.4%, p<0.001) and atrial fibrillation (29.5% vs 21.2%, p<0.001), and had less cardiovascular comorbidities. Acute heart failure was more common in women (32.9 vs 26.9%, p<0.001) and acute renal failure (13.6% vs 11.7%, p<0.001) and sepsis (12.1% vs 9.1%, p<0.001), in men. Women were less likely to undergo cardiac surgery (OR 0.48 - 95%CI 0.40-0.57, p<0.001) and had a higher postoperative mortality (OR 1.84, 95% CI 1.19-2.84, p=0.006). In-hospital mortality rates were comparable between genders (20.3% vs 19.6%, p=0.45). Conclusions: Women were less likely to undergo cardiac surgery when hospitalized with IE, and the female gender was a predictor factor for postoperative mortality. Overall, in-hospital mortality was not influenced by gender. Further research is necessary to fully clarify the impact of gender on IE management and outcomes.
Asunto(s)
Humanos , Masculino , Femenino , Endocarditis Bacteriana/cirugía , Hospitalización , Portugal , Estudios Retrospectivos , Endocarditis Bacteriana/mortalidadRESUMEN
OBJECTIVE: To identify predictors of coronary artery disease in survivors of cardiac arrest, to define the best timing for coronary angiography and to establish the relationship between coronary artery disease and mortality. METHODS: This was a single-center retrospective study including consecutive patients who underwent coronary angiography after cardiac arrest. RESULTS: A total of 117 patients (63 ± 13 years, 77% men) were included. Most cardiac arrest incidents occurred with shockable rhythms (70.1%), and the median duration until the return of spontaneous circulation was 10 minutes. Significant coronary artery disease was found in 68.4% of patients, of whom 75% underwent percutaneous coronary intervention. ST-segment elevation (OR 6.5, 95%CI 2.2 - 19.6; p = 0.001), the presence of wall motion abnormalities (OR 22.0, 95%CI 5.7 - 84.6; p < 0.001), an left ventricular ejection fraction ≤ 40% (OR 6.2, 95%CI 1.8 - 21.8; p = 0.005) and elevated high sensitivity troponin T (OR 3.04, 95%CI 1.3 - 6.9; p = 0.008) were predictors of coronary artery disease; the latter had poor accuracy (area under the curve 0.64; p = 0.004), with an optimal cutoff of 170ng/L. Only ST-segment elevation and the presence of wall motion abnormalities were independent predictors of coronary artery disease. The duration of cardiac arrest (OR 1.015, 95%CI 1.0 - 1.05; p = 0.048) was an independent predictor of death, and shockable rhythm (OR 0.4, 95%CI 0.4 - 0.9; p = 0.031) was an independent predictor of survival. The presence of coronary artery disease and the performance of percutaneous coronary intervention had no impact on survival; it was not possible to establish the best cutoff for coronary angiography timing. CONCLUSION: In patients with cardiac arrest, ST-segment elevation, wall motion abnormalities, left ventricular dysfunction and elevated high sensitivity troponin T were predictive of coronary artery disease. Neither coronary artery disease nor percutaneous coronary intervention significantly impacted survival.
OBJETIVO: Identificar os preditores de doença arterial coronária em sobreviventes à parada cardíaca, visando definir o melhor momento para realização de angiografia coronária e estabelecer o relacionamento entre doença arterial coronária e mortalidade. MÉTODOS: Este foi um estudo retrospectivo em centro único, que incluiu os pacientes consecutivamente submetidos à angiografia coronária após uma parada cardíaca. RESULTADOS: Incluímos 117 pacientes (63 ± 13 anos, 77% homens). A maioria dos incidentes de parada cardíaca ocorreu com ritmos chocáveis (70,1%), e o tempo mediano até retorno da circulação espontânea foi de 10 minutos. Identificou-se doença arterial coronária em 68,4% dos pacientes, dentre os quais 75% foram submetidos à intervenção coronária percutânea. Elevação do segmento ST (RC de 6,5; IC95% 2,2 - 19,6; p = 0,001), presença de alterações da contratilidade segmentar (RC de 22,0; IC95% 5,7 - 84,6; p < 0,001), fração de ejeção ventricular esquerda ≤ 40% (RC de 6,2; IC95% 1,8 - 21,8; p = 0,005) e níveis elevados de troponina T de alta sensibilidade (RC de 3,04; IC95% 1,3 - 6,9; p = 0,008) foram preditores de doença arterial coronária; esse último teve baixa precisão (área sob a curva de 0,64; p = 0,004), tendo o nível de 170ng/L como ponto ideal de corte. Apenas elevação do segmento ST e presença de alterações da contratilidade segmentar foram preditores independentes de doença arterial coronária. A duração da parada cardíaca (RC de 1,015; IC95% 1,0 - 1,05; p = 0,048) foi um preditor independente de óbito, e ritmo chocável (RC de 0,4; IC95% 0,4 - 0,9; p = 0,031) foi um preditor independente de sobrevivência. A presença de doença arterial coronária e a realização de intervenção coronária percutânea não tiveram impacto na sobrevivência; não foi possível estabelecer o melhor ponto de corte para o momento da angiografia coronária. CONCLUSÃO: Em pacientes com parada cardíaca, elevação do segmento ST, alterações da contratilidade segmentar, disfunção ventricular esquerda e níveis elevados de troponina T de alta sensibilidade foram preditivos de doença arterial coronária. Nem doença arterial coronária nem a intervenção coronária percutânea tiveram impacto significante na sobrevivência.
Asunto(s)
Reanimación Cardiopulmonar , Enfermedad de la Arteria Coronaria , Paro Cardíaco Extrahospitalario , Angiografía Coronaria , Enfermedad de la Arteria Coronaria/diagnóstico por imagen , Enfermedad de la Arteria Coronaria/epidemiología , Femenino , Humanos , Masculino , Estudios Retrospectivos , Volumen Sistólico , Sobrevivientes , Función Ventricular IzquierdaRESUMEN
RESUMO Objetivo: Identificar os preditores de doença arterial coronária em sobreviventes à parada cardíaca, visando definir o melhor momento para realização de angiografia coronária e estabelecer o relacionamento entre doença arterial coronária e mortalidade. Métodos: Este foi um estudo retrospectivo em centro único, que incluiu os pacientes consecutivamente submetidos à angiografia coronária após uma parada cardíaca. Resultados: Incluímos 117 pacientes (63 ± 13 anos, 77% homens). A maioria dos incidentes de parada cardíaca ocorreu com ritmos chocáveis (70,1%), e o tempo mediano até retorno da circulação espontânea foi de 10 minutos. Identificou-se doença arterial coronária em 68,4% dos pacientes, dentre os quais 75% foram submetidos à intervenção coronária percutânea. Elevação do segmento ST (RC de 6,5; IC95% 2,2 - 19,6; p = 0,001), presença de alterações da contratilidade segmentar (RC de 22,0; IC95% 5,7 - 84,6; p < 0,001), fração de ejeção ventricular esquerda ≤ 40% (RC de 6,2; IC95% 1,8 - 21,8; p = 0,005) e níveis elevados de troponina T de alta sensibilidade (RC de 3,04; IC95% 1,3 - 6,9; p = 0,008) foram preditores de doença arterial coronária; esse último teve baixa precisão (área sob a curva de 0,64; p = 0,004), tendo o nível de 170ng/L como ponto ideal de corte. Apenas elevação do segmento ST e presença de alterações da contratilidade segmentar foram preditores independentes de doença arterial coronária. A duração da parada cardíaca (RC de 1,015; IC95% 1,0 - 1,05; p = 0,048) foi um preditor independente de óbito, e ritmo chocável (RC de 0,4; IC95% 0,4 - 0,9; p = 0,031) foi um preditor independente de sobrevivência. A presença de doença arterial coronária e a realização de intervenção coronária percutânea não tiveram impacto na sobrevivência; não foi possível estabelecer o melhor ponto de corte para o momento da angiografia coronária. Conclusão: Em pacientes com parada cardíaca, elevação do segmento ST, alterações da contratilidade segmentar, disfunção ventricular esquerda e níveis elevados de troponina T de alta sensibilidade foram preditivos de doença arterial coronária. Nem doença arterial coronária nem a intervenção coronária percutânea tiveram impacto significante na sobrevivência.
ABSTRACT Objective: To identify predictors of coronary artery disease in survivors of cardiac arrest, to define the best timing for coronary angiography and to establish the relationship between coronary artery disease and mortality. Methods: This was a single-center retrospective study including consecutive patients who underwent coronary angiography after cardiac arrest. Results: A total of 117 patients (63 ± 13 years, 77% men) were included. Most cardiac arrest incidents occurred with shockable rhythms (70.1%), and the median duration until the return of spontaneous circulation was 10 minutes. Significant coronary artery disease was found in 68.4% of patients, of whom 75% underwent percutaneous coronary intervention. ST-segment elevation (OR 6.5, 95%CI 2.2 - 19.6; p = 0.001), the presence of wall motion abnormalities (OR 22.0, 95%CI 5.7 - 84.6; p < 0.001), an left ventricular ejection fraction ≤ 40% (OR 6.2, 95%CI 1.8 - 21.8; p = 0.005) and elevated high sensitivity troponin T (OR 3.04, 95%CI 1.3 - 6.9; p = 0.008) were predictors of coronary artery disease; the latter had poor accuracy (area under the curve 0.64; p = 0.004), with an optimal cutoff of 170ng/L. Only ST-segment elevation and the presence of wall motion abnormalities were independent predictors of coronary artery disease. The duration of cardiac arrest (OR 1.015, 95%CI 1.0 - 1.05; p = 0.048) was an independent predictor of death, and shockable rhythm (OR 0.4, 95%CI 0.4 - 0.9; p = 0.031) was an independent predictor of survival. The presence of coronary artery disease and the performance of percutaneous coronary intervention had no impact on survival; it was not possible to establish the best cutoff for coronary angiography timing. Conclusion: In patients with cardiac arrest, ST-segment elevation, wall motion abnormalities, left ventricular dysfunction and elevated high sensitivity troponin T were predictive of coronary artery disease. Neither coronary artery disease nor percutaneous coronary intervention significantly impacted survival.